9PU-63123-02744 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-11
Registered in v-safe
2021-03-11
Dose 1 — Pfizer-BioNTech
2021-03-11
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-03-13
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-16
Survey response — days 1–6 daily, dose 1
MedDRA: Lymphadenopathy — Feeling: Good · Diarrhea

Free text: Swollen lymph node near collarbone on side of body the injection was given

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-20
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-25
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-01
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-08
Health check-in — day 28, dose 1
Feeling: Good

Adult check-in
2021-04-13
Dose 2 — Pfizer-BioNTech
2021-04-14
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-21
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-11
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-18
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-12
Survey response — 6 months, dose 2
MedDRA: Heavy menstrual bleeding, Menstruation irregular — Feeling: Good

Free text: Heavy and irregular periods

MedDRA releases: 2024-11 · check-in free text available
2021-12-01
Dose 3 — Pfizer-BioNTech
2022-04-13
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-06-01
Survey response — 6 months, dose 3
MedDRA: COVID-19, Chills, Oropharyngeal pain, Pain, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Covid 19 infection. Sore throat, fever, body aches, chills.

MedDRA releases: 2024-11 · check-in free text available
2022-11-12
Dose 4 — Pfizer-BioNTech
Co-administered: Flu
2022-12-03
Survey response — 12 months, dose 3
MedDRA: Magnetic resonance imaging abnormal, Microangiopathy, Vertigo — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Mri with indications of small blood vessel disease. Episode of vertigo.

MedDRA releases: 2024-11 · check-in free text available
2022-12-03
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-12-05
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-11	Pfizer-BioNTech
2	2021-04-13	Pfizer-BioNTech
3	2021-12-01	Pfizer-BioNTech	No
4	2022-11-12	Pfizer-BioNTech	Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-16

Systemic reaction (other): Swollen lymph node near collarbone on side of body the injection was given

Release 10 — 6 months, dose 2

2021-10-12

Symptoms: Heavy and irregular periods

Release 11 — 6 months, dose 3

2022-06-01

Symptoms: Covid 19 infection. Sore throat, fever, body aches, chills.

Release 12 — 12 months, dose 3

2022-12-03

Symptoms: Mri with indications of small blood vessel disease. Episode of vertigo.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chills	·	·	✓
SD	COVID-19	·	·	✓
SD	Heavy menstrual bleeding	·	·	✓
SD	Magnetic resonance imaging abnormal	·	·	✓
SD	Menstruation irregular	·	·	✓
SD	Microangiopathy	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	·	·	✓
SD	Pyrexia	·	·	✓
SD	Vertigo	·	·	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release